Renaissance Capital logo

BCYC News

US IPO Week Ahead: IPO market cashes in on crypto as Canaan leads 5-IPO week

CAN

Five IPOs and two SPACs plan to raise $634 million in the week ahead. One of the leading makers of cryptocurrency mining equipment, Canaan (CAN) plans to raise $100 million at a $1.6 billion market cap. It originally filed to raise $400 million (and in 2018 was rumored to be targeting over $1 billion). The #2 player in the space, Canaan has shown that...read more

US IPO Weekly Recap: Two biotechs, a permian pipeline, and 14 filings

IDYA

Three companies raised $776 million this week, adding to what has been a red-hot May for IPOs. One SPAC also raised $250 million. Leading the week was IDEAYA Biosciences (IDYA), which rose 12% on its first day and finished the week at +13% from its IPO. The company, a Phase 1 biotech developing targeted therapies for genetically-defined cancers, raised $50...read more

Cancer biotech Bicycle Therapeutics prices US IPO at $14, the low end of the range

BCYC

Bicycle Therapeutics, a Phase 1 biotech developing novel oncology medicines based on bicyclic peptides, raised $61 million by offering 4.3 million ADSs at $14, the low end of the range of $14 to $16. Insiders had intended to purchase up to $25 million of the IPO. The UK-based company plans to list on the Nasdaq under the symbol BCYC. Goldman Sachs, Jefferies and Piper...read more

US IPO Week Ahead: Permian pipelines go public alongside 3 cancer biotechs

RTLR

Upcoming IPOs include four deals raising $868 million. In addition, a SPAC plans to raise $250 million. Don't expect many new additions to the calendar. After this week, the IPO market will get a short break, as companies hit pause until after Memorial Day. That said, new...read more